5-HT reduction is implicated in depression, and an SSRI-mediated 5-HT increase may normalize beta-receptor down-regulation, offering, in prolonged stress, adaptive self-regulation against excessive CRH–NE activity [40]. The gene discussed is CRH; the disease is major depressive disorder.